CD8A and neoplasm: Napabucasin has been demonstrated to sensitize tumor cells to checkpoint inhibition and it has been linked to high tumor infiltration of CD8+ T cells in mice bearing 4T1 mammary tumors [217], with similar results being reported in mesothelioma [218].